X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Biocon Ltd Fact Sheet, Biocon Ltd Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Biocon Ltd Fact Sheet   (BICN)

Here is the latest financial fact sheet of Biocon Ltd. For more details, see the Biocon Ltd quarterly results and Biocon Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.

BIOCON LTD Price History

Price Rs 329.7
Mkt Cap Rs m 197,820
Vol '000 257.2
P/E X 32.3
P/CF X 16.3
EPS (TTM) Rs 10.2
% ch % -0.7
No. of shares m 600.00
% ch week % -2.6
% ch 1-mth % 4.5
% ch 12-mth % 37.7
52 week H/L Rs 396.0/229.7
(As on Jun 23, 2017 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BIOCON LTD Financials

No. of Mths
Year Ending
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
BIOCON LTD EQUITY SHARE DATA
High Rs385307497554496 
Low Rs243211265407397 
Sales per share (Unadj.) Rs104.3124.3143.9154.5174.3 
Earnings per share (Unadj.) Rs16.925.420.724.944.8 
Diluted earnings per shareRs5.68.56.98.314.9 
Cash flow per share (Unadj.) Rs25.634.430.935.956.9 
Dividends per share (Unadj.) Rs5.007.505.005.005.00 
Adj. dividends per shareRs1.672.501.671.671.67 
Dividend yield (eoy) %1.62.91.31.01.1 
Book value per share (Unadj.) Rs113.6134.7151.3163.5202.8 
Adj. book value per shareRs37.944.950.454.567.6 
Shares outstanding (eoy) m200.00200.00200.00200.00200.00 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x3.02.12.63.12.6 
Avg P/E ratio x18.610.218.419.310.0 
P/CF ratio (eoy) x12.27.512.313.47.8 
Price / Book Value ratio x2.81.92.52.92.2 
Dividend payout %29.629.524.220.111.2 
Avg Mkt Cap Rs m62,80051,79076,19096,08089,220 
No. of employees `0006.36.77.37.54.4 
Total wages/salary Rs m3,0763,8944,6635,3346,363 
Avg. sales/employee Rs Th3,336.83,694.53,936.14,119.77,894.5 
Avg. wages/employee Rs Th491.9578.9637.9711.21,441.2 
Avg. net profit/employee Rs Th541.2756.5566.1663.22,029.7 
BIOCON LTD INCOME DATA
Net Sales Rs m20,86524,85328,77330,89834,854 
Other income Rs m618527559531845 
Total revenues Rs m21,48325,38029,33231,42935,699 
Gross profit Rs m5,1735,4306,8716,9588,200 
Depreciation Rs m1,7441,7932,0362,2102,423 
Interest Rs m122811789102 
Profit before tax Rs m3,9254,0835,3775,1906,520 
Minority Interest Rs m0-38-170-310-744 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m02,01901,0515,754 
Tax Rs m5419751,0699572,569 
Profit after tax Rs m3,3845,0894,1384,9748,961 
Gross profit margin %24.821.823.922.523.5 
Effective tax rate %13.823.919.918.439.4 
Net profit margin %16.220.514.416.125.7 
BIOCON LTD BALANCE SHEET DATA
Current assets Rs m19,99722,40026,38825,62639,932 
Current liabilities Rs m10,1589,89913,79615,54716,276 
Net working cap to sales %47.250.343.832.667.9 
Current ratio x2.02.31.91.62.5 
Inventory Days Days6659485354 
Debtors Days Days8675769186 
Net fixed assets Rs m16,60018,22827,30833,06539,101 
Share capital Rs m1,0001,0001,0001,0001,000 
"Free" reserves Rs m20,74524,07927,04730,77838,591 
Net worth Rs m22,72426,94630,26732,70640,556 
Long term debt Rs m6981,6406,0627,69620,724 
Total assets Rs m39,37244,16157,50663,75484,816 
Interest coverage x33.251.4317.359.364.9 
Debt to equity ratio x00.10.20.20.5 
Sales to assets ratio x0.50.60.50.50.4 
Return on assets %8.911.77.27.910.7 
Return on equity %14.918.913.715.222.1 
Return on capital %17.321.514.414.919.0 
Exports to sales %31.938.037.133.530.7 
Imports to sales %21.522.422.819.720.4 
Exports (fob) Rs m6,6619,45010,66910,33910,717 
Imports (cif) Rs m4,4815,5616,5736,1027,105 
Fx inflow Rs m6,7739,90610,80310,99311,789 
Fx outflow Rs m5,4496,3307,7157,3718,393 
Net fx Rs m1,3243,5763,0883,6223,396 
BIOCON LTD CASH FLOW
From Operations Rs m 5,641 4,712 5,607 2,107 5,264 
From Investments Rs m -3,595 -3,758 -9,381 -5,087 -9,540 
From Financial Activity Rs m -1,863 -86 4,260 1,862 10,867 
Net Cashflow Rs m 183 868 486 -1,118 6,591 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 40.4%
Foreign collaborators 20.6%
Indian inst/Mut Fund 8.4%
FIIs 10.7%
ADR/GDR 0.0%
Free float 19.9%
Shareholders 109,995
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 20th KM, Hosur Road, Electronic City, Bangalore - 560 100
E-MAIL kiran.kumar@biocon.com WEB www.biocon.com
TELEPHONE (080) 2808 2037 FAX (080) 2852 3423
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR S. R. Batliboi & Assoc.
CHM: Kiran Mazumdar Shaw (MD) COMP SEC: Kiran Kumar YEAR OF INC: 1978 BSE CODE: 532523 FV (Rs): 5 DIV YIELD (%): 0.5

More Pharmaceuticals Company Fact Sheets:   INDOCO REMEDIES  FRESENIUS KABI ONCO.  ASTRAZENECA PHARMA  MERCK LTD  FULFORD INDIA  

Compare BIOCON LTD With:   INDOCO REMEDIES  FRESENIUS KABI ONCO.  ASTRAZENECA PHARMA  MERCK LTD  FULFORD INDIA  

Compare BIOCON LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Share Markets End the Week on a Dull Note(RoundUp)

Global financial markets ended the week on a dull note. This was on back of the Federal Reserve's release of its May 2-3 policy meeting minutes.

Views on news

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

More Views on News

Most Popular

A Pharma IPO in a Market That Loves IPOs but Hates Pharma(The 5 Minute Wrapup)

Jun 15, 2017

Tomorrow comes the IPO of Eris Lifesciences. How will a pharma IPO do in this market?

Bitcoin at $10,000?(Vivek Kaul's Diary)

Jun 14, 2017

Whether you're Venezuela or China or in India or the US...and you want to protect your wealth, you need real money. All the government has on offer is funny money.

Get Ready for Commodity Options!(Daily Profit Hunter)

Jun 16, 2017

Commodity options trading is one step closer to reality. Learn how to take advantage of this tremendous opportunity.

Walter Schloss' Investing Record(Chart Of The Day)

Jun 17, 2017

In a market full of one-hit-wonders, this investor obviously had a formula that worked. And through the think-and-thin of the market.

11 Hidden Costs Associated With Your Home Loan(Outside View)

Jun 16, 2017

Various costs associated with a home loan.

More

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON BIOCON LTD

BIOCON LTD - ADCOCK INGRAM COMPARISON

COMPARE BIOCON LTD WITH

MARKET STATS